Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer

Breast Cancer Research and Treatment

Volumn 42, Issue 2, 1997, Pages 183-186

  Pronzato, P ^a   Queirolo, P ^b   Landucci, M ^a   Vaira, F ^a   Vigani, A ^a   Gipponi, M ^b   Cafiero, F ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Ifosfamide; Metastatic breast cancer; Second line chemotherapy; Vinorelbine

Indexed keywords

ANTHRACYCLINE; ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; IFOSFAMIDE; MESNA; NAVELBINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; NEOPLASM METASTASIS; VINBLASTINE;

EID: 0031019446     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005720431557     Document Type: Article

References (23)

1. Tormey CD: Adryamicin (NSC-123127) in breast cancer: an overview of studies. Cancer Chemother Rep 6: 319-327, 1975
2. Bonadonna G, Gianni L, Santoro A et al.: Drugs ten years later: Epirubicin (review). Ann Oncol 4: 359-369, 1993
3. Brambilla C, Rossi A, Bonfante V et al.: Phase II study with doxorubicin vs epirubicin in advanced breast cancer. Cancer Treat Rep 70: 261-266, 1986
4. Henderson IC, Garber JE, Breitmeyer JB et al.: Comprehensive management of disseminated breast cancer. Cancer 66:1439-1448, 1990
5. Pronzato P, Bertelli G, Vaira F et al.: Mitoxantrone and 5-fluorouracil modulated by the pure (6S) stereoisomer of leucovorin as second-line chemotherapy for advanced breast cancer, Eur J Cancer 30A: 1593-1594, 1994
6. Repetto L, Miglietta L, Gardin G et al.: Mitoxantrone and mitomycin as second-line treatment for advanced breast cancer. Ann Oncol 3 165-166, 1992
7. Pronzato P, Queirolo P, Vidili MG et al.: Continuous venous infusion of vinblastine in metastatic breast cancer. Chemotherapy 37:146-149, 1991
8. Amoroso D, Bertelli G, Pronzato P et al.: Continuous venous infusion of vindesine in metastatic breast cancer: experience with a subcutaneously implanted system and portable pump. Anticancer Res 9: 141-144, 1989
9. Hoogenstraten AB, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 207-214, 1981
10. Krikorian A, Rahmani R, Bromet M et al.: Pharmacokinetics and metabolism of navelbine. Semin Oncol 16(2) suppl 4: 21-25, 1989
11. Hortobagyi GH: Future direction for vinorelbine. Semin Oncol 22(2) suppl 5: 80-87, 1995
12. Fumoleau P, Delozier T, Extra JM et al.: Vinorelbine in the treatment of breast cancer: the European experience. Semin Oncol 22(2): 22-29, 1995
13. Canobbio L, Boccardo F, Pastorino G et al.: Phase II study of navelbine in advanced breast cancer. Semin Oncol 16(2): 33-36, 1989
14. Gasparini G, Caffo O, Barni S et al.: Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study. J Clin Oncol 12: 2094-2101, 1994
15. Hortobagyi GH: Activity of ifosfamide in breast cancer. Semin Oncol 4: 14-20, 1982
16. Brema F, Porcile GF, Parodi GC et al.: Clinical evaluation of ifosfamide in solid epithelial advanced tumors. Clin Pharmacol Ther 5: 122-126, 1977
17. Goldin A: Ifosfamide in experimental tumor systems. Semin Oncol 4: 14-18, 1982
18. Bramwell VH, Mouridsen HT, Santoro A et al.: Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol 23: 311-316, 1987
19. Budzar AU, Legha SS, Tashima CK et al.: Ifosfamide vs cyclophosphamide in combination drug therapy for metastatic breast cancer. Cancer Treat Rep 63: 115-120, 1979
20. Sanchiz F, Milla A: High dose ifosfamide and Mesna in advanced breast cancer. Cancer Chemother Pharmacol 26:91-92, 1990
21. Ghavamzadeh A: Treatment of metastatic breast cancer with the combination of ifosfamide, epirubicin and 5-fluorouracil. Cancer Chemother Pharmacol 26: 66-68, 1990
22. Lewi S, Litowska S: Phase II study of vinorelbine and ifosfamide for non small cell lung cancer. Proceedings of ASCO. abs 1071 (13), Dallas, May 1994
23. Leone B, Vallejo C, Romero A et al.: Ifosfamide and vinorelbine as first line chemotherapy for metastatic breast cancer. Proceedings of ASCO, abs 187 (14), Los Angeles, May 1995